Supplementary protection
LT - Fluoru pakeisti cikloalkano- indolai ir jų, kaip prostaglandino D2 receptoriaus antagonistų, panaudojimas
EN - FLUORO SUBSTITUTED CYCLOALKANOINDOLES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS
SPC
| (11) |
Number of the document |
C 1470107 |
| (68) |
Number of the document |
1470107
|
| (21) |
Application number for Supplementary Protection Certificate |
PA 2009 001 |
| (22) |
Date of filing the application |
2009-03-25 |
| (41) |
Date of publication of the application |
2009-05-25 |
|
Date of publication of SPC |
2010-02-25 |
| (24) |
Date of coming into effect of SPC |
2023-01-23 |
Applicant
| (71) |
Merck Frosst Canada Ltd.,
16711 Trans-Canada Highway, Kirkland, Québec H9H 3L1,
CA
|
Grantee
| (73) |
Merck Frosst Canada Ltd.,
16711 Trans-Canada Highway, Kirkland, Québec H9H 3L1,
CA
|
Attorney or representative
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
| (93) |
EU/1/08/459/001-EU/1/08/459/011 2008 07 03, EU/1/08/458/001-EU/1/08/458/011 2008 07 03, EU/1/08/460/001-EU/1/08/460/011, 2008-07-03
|
Calculated date of expiry of the SPC
| (94) |
2023-07-03 |
Name of the product protected by the basic patent
| (95) |
Acidum nicotinicum/Laropiprantum |
Legal status
|
SPC lapsed (non-payment of fees for the main patent)
|
|
